Literature DB >> 12958307

Early identification of human cytomegalovirus strains by the shell vial assay is prevented by a novel amino acid substitution in UL123 IE1 gene product.

G Gerna, F Baldanti, E Percivalle, M Zavattoni, G Campanini, M G Revello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12958307      PMCID： PMC193824          DOI： 10.1128/JCM.41.9.4494-4495.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  7 in total

1.  Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene.

Authors:  M C Mazeron; G Jahn; B Plachter
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

2.  Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen.

Authors:  C A Gleaves; T F Smith; E A Shuster; G R Pearson
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

3.  Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.

Authors:  G Gerna; M G Revello; E Percivalle; M Zavattoni; M Parea; M Battaglia
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  Identification of human cytomegalovirus strain with immediate-early (IE) antigen-specific monoclonal antibody is prevented by point mutation in IE gene.

Authors:  D Zipeto; A Sarasini; F Rossi; F Baldanti; M G Revello; G Milanesi; G Gerna
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

5.  Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

Authors:  G Gerna; M Furione; F Baldanti; A Sarasini
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

Review 6.  Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Authors:  Maria Grazia Revello; Giuseppe Gerna
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

7.  Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.

Authors:  G Gerna; M G Revello; E Percivalle; F Morini
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948
  7 in total
  4 in total

1.  Measurement of the sensitivity of different commercial assays in the diagnosis of CMV infection in pregnancy.

Authors:  M Gentile; C Galli; P Pagnotti; P Di Marco; S Tzantzoglou; F Bellomi; M L Ferreri; C Selvaggi; G Antonelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-10       Impact factor: 3.267

2.  Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection.

Authors:  G Lombardi; F Garofoli; P Villani; M Tizzoni; M Angelini; M Cusato; L Bollani; A De Silvestri; M Regazzi; M Stronati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-11       Impact factor: 3.267

3.  Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.

Authors:  Daniele Lilleri; Anna Kabanova; Antonio Lanzavecchia; Giuseppe Gerna
Journal:  J Clin Immunol       Date:  2012-07-27       Impact factor: 8.317

4.  Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.

Authors:  Daniele Lilleri; Anna Kabanova; Maria Grazia Revello; Elena Percivalle; Antonella Sarasini; Emilia Genini; Federica Sallusto; Antonio Lanzavecchia; Davide Corti; Giuseppe Gerna
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.